九安医疗：拟注销977.19万股股份

Core Viewpoint - The company plans to change the purpose of repurchasing 9,106,900 shares, which were bought back on August 29, 2023, to "cancel and reduce the company's registered capital" [1] Group 1: Share Repurchase and Capital Reduction - The number of shares to be canceled is 9,771,900, accounting for 2.06% of the company's current total share capital [1] - After the cancellation, the total share capital will decrease from 475 million shares to 465 million shares [1] - This move aims to actively maintain the company's market value and enhance shareholder returns [1] Group 2: Financial Impact - The change in the purpose of the repurchased shares and the cancellation will not have a significant impact on the company's financial condition, operating results, or future development [1] - There will be no change in the controlling shareholder or actual controller of the company as a result of this action [1]